2
Belen Garijo
Chief Executive Officer
Legacy
Leads Sanofi's next phase as a focused science-led biopharmaceutical company.
Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
2 leaders · Full leadership timeline
Sanofi is a Paris-based biopharmaceutical company with FY2025 net sales of EUR43.626 billion and 74,846 employees. It operates across specialty medicines, vaccines, rare diseases, and general medicines, and is moving toward a more focused science-led model under CEO Belen Garijo.
Sanofi makes money by discovering, developing, manufacturing, and selling prescription medicines and vaccines through direct sales teams, hospital channels, wholesalers, pharmacies, and government procurement programs. Major revenue drivers include specialty medicines such as Dupixent, rare disease therapies, vaccines, and established general medicines.
Chief Executive Officer
Leads Sanofi's next phase as a focused science-led biopharmaceutical company.
Former Chief Executive Officer
Led the Play to Win strategy and the sharper focus on specialty medicines and vaccines.
Sanofi faces patent and biosimilar risk, drug pricing pressure, reimbursement reviews, R&D execution risk, manufacturing complexity, and product concentration around major growth brands such as Dupixent.